The Year in Lipid Disorders, 1.

Format:

Book

Author/Creator:

Packard, C.

Series:

Year in

Language:

English

Subjects (All):

Hyperlipidemia.

Lipids--Metabolism--Disorders--Treatment.

Lipids--Metabolism--Disorders.

Lipids--Metabolism.

Lipids.

Metabolism--Disorders.

Local Subjects:

Hyperlipidemia.

Lipids--Metabolism--Disorders--Treatment.

Lipids--Metabolism--Disorders.

Lipids--Metabolism.

Lipids.

Metabolism--Disorders.

Physical Description:

1 online resource (388 p.)

Edition:

1st ed.

Place of Publication:

Oxford : Atlas Medical Publishing Ltd, 2007.

Language Note:

English

Summary:

Lipid disorders are among the primary risk factors in developing atherosclerosis and heart disease. Cardiovascular diseases are the leading cause of death world-wide in both genders. This book provides the inquiring physician with an up-to-date insight into the latest research into lipid disorders, and the implications of this research for daily clinical practice. The book provides an overview of the latest developments in this complex field by reviewing the most significant papers published in the medical journals on lipid disorders over the eighteen months to December 2006. The Year in Lipid

Contents:

Editor and Contributors; Part I: Clinical aspects in coronary artery disease; 1. Metabolic syndrome, diabetes and cardiovascular risk; 2. Use of novel risk factors in prevention and therapeutic strategies; 3. Diet and exercise in the prevention and treatment of diabetes and coronary heart disease; 4. Technologies for assessment of atherosclerotic burden in man; Part II: Lipids, lipoproteins andatherosclerosis; 5. High-density lipoprotein structure and metabolism: regulation by cell membrane receptors; 6. Oxidative stress, lipoprotein oxidation and atherosclerosis

7. Metabolism of apolipoprotein B-100-containing lipoproteins in dyslipidaemias8. Sex-specific aspects of dyslipidaemia and atherosclerosis; Part III: Prevention and treatment strategies; 9. New clinical trials oflipid-regulating agents; 10. Genetics of dyslipidaemia andcoronary risk (personalized lipid-lowering treatment); 11. Application of proteomic, metabolomic and lipidomic approaches to coronary heart disease risk prediction; 12. Nuclear receptors (PPARs, LXRs) and their role in regulating lipid metabolism; Part IV: Infection, inflammation and secondary causes of atherosclerosis

13. Inflammation, inflammatory disease, and coronary atherosclerosis14. Kidney disease, end-stage renal failure and accelerated coronary heart disease; 15. Lipids and infection; 16.Haemostasis-dyslipidaemia interactions in coronary heart disease; Abbreviations; Index of papers reviewed; General index

Notes:

Description based upon print version of record.

Description based on publisher supplied metadata and other sources.

ISBN:

9786611408503

9781281408501

1281408506

9781846925733

1846925738

OCLC:

476193525